Comparison Performance Vigileo vs. Continuous CCO (Vigilance) in Patients With Induced Therapeutic Hypothermia
NCT ID: NCT00626899
Last Updated: 2010-01-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
8 participants
OBSERVATIONAL
2007-03-31
2008-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ventilation in Cardiac Arrest
NCT04657393
Cerebral Oxygenation in Cardiac Arrest and Hypothermia
NCT01531426
Pulse Contour Analysis and Tissue Oxymetry in Changing Vascular Tone
NCT00583687
The Feasibility and Accuracy of Exhaled CO2 to Measure Cardiac Output in Ventilated Patients Without Tracheal Intubation
NCT00783679
PEEP vs. ZEEP in Out-of-Hospital-Cardiac-Arrest
NCT06836830
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* pulmonary arterial catheter placed by treating physician
Exclusion Criteria
* Aortic valve insufficiency (moderate to severe)
* placement of intra-aortic balloon pump (IABP) or a LVAD (left ventricular assist device)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Insel Gruppe AG, University Hospital Bern
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Department of Intensive Care Medicine, University Hospital Bern - Inselspital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Matthias Haenggi, MD
Role: PRINCIPAL_INVESTIGATOR
Departement of Intensive Care Medicine, University Hospital Bern, Inselspital, Bern, Switzerland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Departement of Intensive Care Medicine - University Hospital Bern - Inselspital
Bern, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KIM-Vig/Vig
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.